Developing GST inhibitors by an electrophilicity-based strategy. A novel analog of piperlongumine (PL-13) as a GST inhibitor was synthesized. PL-13 displayed the strongest electrophilicity and GST-inhibitory activity. PL-13 could effectively overcome cisplatin resistance in lung cancer A549 cells.